Skip to contents

[Deprecated]

Usage

cdisc_data_file(path, code = get_code(path))

Arguments

path

A (connection) or a (character)
string giving the pathname of the file or URL to read from. "" indicates the connection stdin.

code

(character)
reproducible code to re-create object

Value

TealData object

Examples

file_example <- tempfile(fileext = ".R")
writeLines(
  text = c(
    "library(scda)

     # code>
     ADSL <- synthetic_cdisc_data('latest')$adsl
     ADTTE <- synthetic_cdisc_data('latest')$adtte

     cdisc_data(
          cdisc_dataset(\"ADSL\", ADSL), cdisc_dataset(\"ADTTE\", ADTTE),
          code = \"ADSL <- synthetic_cdisc_data('latest')$adsl
                  ADTTE <- synthetic_cdisc_data('latest')$adtte\",
          check = FALSE
     )
     # <code"
  ),
  con = file_example
)

cdisc_data_file(file_example)
#> Warning: `cdisc_data_file()` was deprecated in teal.data 0.1.3.
#>  Please use `teal_data_file()` instead.
#> A TealData object containing 2 TealDataset/TealDatasetConnector object(s) as element(s):
#> --> Element 1:
#> A CDISCTealDataset object containing the following data.frame (400 rows and 55 columns):
#>   STUDYID               USUBJID SUBJID SITEID AGE  AGEU SEX
#> 1 AB12345  AB12345-CHN-3-id-128 id-128  CHN-3  32 YEARS   M
#> 2 AB12345 AB12345-CHN-15-id-262 id-262 CHN-15  35 YEARS   M
#> 3 AB12345  AB12345-RUS-3-id-378 id-378  RUS-3  30 YEARS   F
#> 4 AB12345 AB12345-CHN-11-id-220 id-220 CHN-11  26 YEARS   F
#> 5 AB12345  AB12345-CHN-7-id-267 id-267  CHN-7  40 YEARS   M
#> 6 AB12345 AB12345-CHN-15-id-201 id-201 CHN-15  49 YEARS   M
#>                        RACE                 ETHNIC COUNTRY DTHFL         INVID
#> 1                     ASIAN     HISPANIC OR LATINO     CHN     Y  INV ID CHN-3
#> 2 BLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINO     CHN     N INV ID CHN-15
#> 3                     ASIAN NOT HISPANIC OR LATINO     RUS     N  INV ID RUS-3
#> 4                     ASIAN NOT HISPANIC OR LATINO     CHN     N INV ID CHN-11
#> 5                     ASIAN NOT HISPANIC OR LATINO     CHN     N  INV ID CHN-7
#> 6                     ASIAN NOT HISPANIC OR LATINO     CHN     Y INV ID CHN-15
#>           INVNAM            ARM ARMCD         ACTARM ACTARMCD         TRT01P
#> 1  Dr. CHN-3 Doe      A: Drug X ARM A      A: Drug X    ARM A      A: Drug X
#> 2 Dr. CHN-15 Doe C: Combination ARM C C: Combination    ARM C C: Combination
#> 3  Dr. RUS-3 Doe C: Combination ARM C C: Combination    ARM C C: Combination
#> 4 Dr. CHN-11 Doe     B: Placebo ARM B     B: Placebo    ARM B     B: Placebo
#> 5  Dr. CHN-7 Doe     B: Placebo ARM B     B: Placebo    ARM B     B: Placebo
#> 6 Dr. CHN-15 Doe C: Combination ARM C C: Combination    ARM C C: Combination
#>           TRT01A         TRT02P         TRT02A REGION1 STRATA1 STRATA2
#> 1      A: Drug X     B: Placebo      A: Drug X    Asia       C      S2
#> 2 C: Combination     B: Placebo C: Combination    Asia       C      S1
#> 3 C: Combination      A: Drug X     B: Placebo Eurasia       A      S1
#> 4     B: Placebo     B: Placebo     B: Placebo    Asia       B      S2
#> 5     B: Placebo C: Combination      A: Drug X    Asia       C      S1
#> 6 C: Combination     B: Placebo C: Combination    Asia       C      S2
#>      BMRKR1 BMRKR2 ITTFL SAFFL BMEASIFL BEP01FL AEWITHFL     RANDDT
#> 1 14.424934 MEDIUM     Y     Y        Y       Y        N 2019-02-22
#> 2  4.055463    LOW     Y     Y        N       N        Y 2019-02-26
#> 3  2.803240   HIGH     Y     Y        Y       N        N 2019-02-24
#> 4 10.262734 MEDIUM     Y     Y        Y       Y        N 2019-02-27
#> 5  6.206763    LOW     Y     Y        N       N        N 2019-03-01
#> 6  6.906799 MEDIUM     Y     Y        Y       N        N 2019-03-05
#>               TRTSDTM             TRTEDTM           TRT01SDTM
#> 1 2019-02-24 11:09:25 2022-02-12 04:28:08 2019-02-24 11:09:25
#> 2 2019-02-26 09:05:10 2022-02-26 03:05:10 2019-02-26 09:05:10
#> 3 2019-02-28 03:19:22 2022-02-27 21:19:22 2019-02-28 03:19:22
#> 4 2019-03-01 13:33:19 2022-03-01 07:33:19 2019-03-01 13:33:19
#> 5 2019-03-02 00:09:33 2022-03-01 18:09:33 2019-03-02 00:09:33
#> 6 2019-03-05 15:24:07 2022-02-19 04:06:48 2019-03-05 15:24:07
#>             TRT01EDTM           TRT02SDTM           TRT02EDTM
#> 1 2021-02-11 22:28:08 2021-02-11 22:28:08 2022-02-12 04:28:08
#> 2 2021-02-25 21:05:10 2021-02-25 21:05:10 2022-02-26 03:05:10
#> 3 2021-02-27 15:19:22 2021-02-27 15:19:22 2022-02-27 21:19:22
#> 4 2021-03-01 01:33:19 2021-03-01 01:33:19 2022-03-01 07:33:19
#> 5 2021-03-01 12:09:33 2021-03-01 12:09:33 2022-03-01 18:09:33
#> 6 2021-02-18 22:06:48 2021-02-18 22:06:48 2022-02-19 04:06:48
#>              AP01SDTM            AP01EDTM            AP02SDTM
#> 1 2019-02-24 11:09:25 2021-02-11 22:28:08 2021-02-11 22:28:08
#> 2 2019-02-26 09:05:10 2021-02-25 21:05:10 2021-02-25 21:05:10
#> 3 2019-02-28 03:19:22 2021-02-27 15:19:22 2021-02-27 15:19:22
#> 4 2019-03-01 13:33:19 2021-03-01 01:33:19 2021-03-01 01:33:19
#> 5 2019-03-02 00:09:33 2021-03-01 12:09:33 2021-03-01 12:09:33
#> 6 2019-03-05 15:24:07 2021-02-18 22:06:48 2021-02-18 22:06:48
#>              AP02EDTM       EOSSTT       EOTSTT      EOSDT EOSDY DCSREAS
#> 1 2022-02-12 04:28:08 DISCONTINUED DISCONTINUED 2022-02-12  1084   DEATH
#> 2 2022-02-26 03:05:10    COMPLETED    COMPLETED 2022-02-26  1096    <NA>
#> 3 2022-02-27 21:19:22    COMPLETED    COMPLETED 2022-02-27  1096    <NA>
#> 4 2022-03-01 07:33:19    COMPLETED    COMPLETED 2022-03-01  1096    <NA>
#> 5 2022-03-01 18:09:33    COMPLETED    COMPLETED 2022-03-01  1096    <NA>
#> 6 2022-02-19 04:06:48 DISCONTINUED DISCONTINUED 2022-02-19  1082   DEATH
#>        DTHDT       DTHCAUS        DTHCAT LDDTHELD LDDTHGR1   LSTALVDT DTHADY
#> 1 2022-03-06 ADVERSE EVENT ADVERSE EVENT       22     <=30 2022-03-06   1105
#> 2       <NA>          <NA>          <NA>       NA     <NA> 2022-03-17     NA
#> 3       <NA>          <NA>          <NA>       NA     <NA> 2022-03-11     NA
#> 4       <NA>          <NA>          <NA>       NA     <NA> 2022-03-26     NA
#> 5       <NA>          <NA>          <NA>       NA     <NA> 2022-03-15     NA
#> 6 2022-02-22 ADVERSE EVENT ADVERSE EVENT        3     <=30 2022-02-22   1084
#>   ADTHAUT
#> 1     Yes
#> 2    <NA>
#> 3    <NA>
#> 4    <NA>
#> 5    <NA>
#> 6     Yes
#> ...
#> --> Element 2:
#> A CDISCTealDataset object containing the following data.frame (2000 rows and 67 columns):
#>   STUDYID              USUBJID SUBJID SITEID AGE  AGEU SEX
#> 1 AB12345 AB12345-BRA-1-id-105 id-105  BRA-1  38 YEARS   M
#> 2 AB12345 AB12345-BRA-1-id-105 id-105  BRA-1  38 YEARS   M
#> 3 AB12345 AB12345-BRA-1-id-105 id-105  BRA-1  38 YEARS   M
#> 4 AB12345 AB12345-BRA-1-id-105 id-105  BRA-1  38 YEARS   M
#> 5 AB12345 AB12345-BRA-1-id-105 id-105  BRA-1  38 YEARS   M
#> 6 AB12345 AB12345-BRA-1-id-134 id-134  BRA-1  47 YEARS   M
#>                        RACE                 ETHNIC COUNTRY DTHFL        INVID
#> 1 BLACK OR AFRICAN AMERICAN     HISPANIC OR LATINO     BRA     N INV ID BRA-1
#> 2 BLACK OR AFRICAN AMERICAN     HISPANIC OR LATINO     BRA     N INV ID BRA-1
#> 3 BLACK OR AFRICAN AMERICAN     HISPANIC OR LATINO     BRA     N INV ID BRA-1
#> 4 BLACK OR AFRICAN AMERICAN     HISPANIC OR LATINO     BRA     N INV ID BRA-1
#> 5 BLACK OR AFRICAN AMERICAN     HISPANIC OR LATINO     BRA     N INV ID BRA-1
#> 6                     WHITE NOT HISPANIC OR LATINO     BRA     Y INV ID BRA-1
#>          INVNAM       ARM ARMCD    ACTARM ACTARMCD    TRT01P    TRT01A
#> 1 Dr. BRA-1 Doe A: Drug X ARM A A: Drug X    ARM A A: Drug X A: Drug X
#> 2 Dr. BRA-1 Doe A: Drug X ARM A A: Drug X    ARM A A: Drug X A: Drug X
#> 3 Dr. BRA-1 Doe A: Drug X ARM A A: Drug X    ARM A A: Drug X A: Drug X
#> 4 Dr. BRA-1 Doe A: Drug X ARM A A: Drug X    ARM A A: Drug X A: Drug X
#> 5 Dr. BRA-1 Doe A: Drug X ARM A A: Drug X    ARM A A: Drug X A: Drug X
#> 6 Dr. BRA-1 Doe A: Drug X ARM A A: Drug X    ARM A A: Drug X A: Drug X
#>           TRT02P    TRT02A       REGION1 STRATA1 STRATA2   BMRKR1 BMRKR2 ITTFL
#> 1 C: Combination A: Drug X South America       B      S1 4.156914 MEDIUM     Y
#> 2 C: Combination A: Drug X South America       B      S1 4.156914 MEDIUM     Y
#> 3 C: Combination A: Drug X South America       B      S1 4.156914 MEDIUM     Y
#> 4 C: Combination A: Drug X South America       B      S1 4.156914 MEDIUM     Y
#> 5 C: Combination A: Drug X South America       B      S1 4.156914 MEDIUM     Y
#> 6     B: Placebo A: Drug X South America       B      S2 6.462991    LOW     Y
#>   SAFFL BMEASIFL BEP01FL AEWITHFL     RANDDT             TRTSDTM
#> 1     Y        Y       Y        N 2020-03-08 2020-03-08 05:39:28
#> 2     Y        Y       Y        N 2020-03-08 2020-03-08 05:39:28
#> 3     Y        Y       Y        N 2020-03-08 2020-03-08 05:39:28
#> 4     Y        Y       Y        N 2020-03-08 2020-03-08 05:39:28
#> 5     Y        Y       Y        N 2020-03-08 2020-03-08 05:39:28
#> 6     Y        Y       N        N 2020-11-03 2020-11-04 04:08:58
#>               TRTEDTM           TRT01SDTM           TRT01EDTM
#> 1 2022-02-14 20:58:26 2020-03-08 05:39:28 2021-02-14 14:58:26
#> 2 2022-02-14 20:58:26 2020-03-08 05:39:28 2021-02-14 14:58:26
#> 3 2022-02-14 20:58:26 2020-03-08 05:39:28 2021-02-14 14:58:26
#> 4 2022-02-14 20:58:26 2020-03-08 05:39:28 2021-02-14 14:58:26
#> 5 2022-02-14 20:58:26 2020-03-08 05:39:28 2021-02-14 14:58:26
#> 6 2022-02-20 03:33:55 2020-11-04 04:08:58 2021-02-19 21:33:55
#>             TRT02SDTM           TRT02EDTM            AP01SDTM
#> 1 2021-02-14 14:58:26 2022-02-14 20:58:26 2020-03-08 05:39:28
#> 2 2021-02-14 14:58:26 2022-02-14 20:58:26 2020-03-08 05:39:28
#> 3 2021-02-14 14:58:26 2022-02-14 20:58:26 2020-03-08 05:39:28
#> 4 2021-02-14 14:58:26 2022-02-14 20:58:26 2020-03-08 05:39:28
#> 5 2021-02-14 14:58:26 2022-02-14 20:58:26 2020-03-08 05:39:28
#> 6 2021-02-19 21:33:55 2022-02-20 03:33:55 2020-11-04 04:08:58
#>              AP01EDTM            AP02SDTM            AP02EDTM       EOSSTT
#> 1 2021-02-14 14:58:26 2021-02-14 14:58:26 2022-02-14 20:58:26 DISCONTINUED
#> 2 2021-02-14 14:58:26 2021-02-14 14:58:26 2022-02-14 20:58:26 DISCONTINUED
#> 3 2021-02-14 14:58:26 2021-02-14 14:58:26 2022-02-14 20:58:26 DISCONTINUED
#> 4 2021-02-14 14:58:26 2021-02-14 14:58:26 2022-02-14 20:58:26 DISCONTINUED
#> 5 2021-02-14 14:58:26 2021-02-14 14:58:26 2022-02-14 20:58:26 DISCONTINUED
#> 6 2021-02-19 21:33:55 2021-02-19 21:33:55 2022-02-20 03:33:55 DISCONTINUED
#>         EOTSTT      EOSDT EOSDY            DCSREAS      DTHDT       DTHCAUS
#> 1 DISCONTINUED 2022-02-14   709 PROTOCOL VIOLATION       <NA>          <NA>
#> 2 DISCONTINUED 2022-02-14   709 PROTOCOL VIOLATION       <NA>          <NA>
#> 3 DISCONTINUED 2022-02-14   709 PROTOCOL VIOLATION       <NA>          <NA>
#> 4 DISCONTINUED 2022-02-14   709 PROTOCOL VIOLATION       <NA>          <NA>
#> 5 DISCONTINUED 2022-02-14   709 PROTOCOL VIOLATION       <NA>          <NA>
#> 6 DISCONTINUED 2022-02-20   473              DEATH 2022-03-16 ADVERSE EVENT
#>          DTHCAT LDDTHELD LDDTHGR1   LSTALVDT DTHADY ADTHAUT ASEQ TTESEQ
#> 1          <NA>       NA     <NA> 2022-03-09     NA    <NA>    4      4
#> 2          <NA>       NA     <NA> 2022-03-09     NA    <NA>    2      2
#> 3          <NA>       NA     <NA> 2022-03-09     NA    <NA>    3      3
#> 4          <NA>       NA     <NA> 2022-03-09     NA    <NA>    1      1
#> 5          <NA>       NA     <NA> 2022-03-09     NA    <NA>   NA     NA
#> 6 ADVERSE EVENT       24     <=30 2022-03-16    496     Yes    2      2
#>                            PARAM PARAMCD      AVAL AVALU                ADTM
#> 1 Duration of Confirmed Response    CRSD 1273.8498  DAYS 2021-05-27 05:39:28
#> 2            Event Free Survival     EFS  135.9787  DAYS 2020-09-25 05:39:28
#> 3               Overall Survival      OS 1759.8678  DAYS 2020-11-25 05:39:28
#> 4      Progression Free Survival     PFS  241.1912  DAYS 2020-03-30 05:39:28
#> 5  Total Number of Exacerbations     TNE    1.0000 COUNT                <NA>
#> 6 Duration of Confirmed Response    CRSD  544.5728  DAYS 2021-10-05 04:08:58
#>   ADY CNSR                    EVNTDESC                   CNSDTDSC lgTMATRSK
#> 1 445    1 Last Date Known To Be Alive End of AE Reporting Period        NA
#> 2 201    0                       Death                                   NA
#> 3 262    0                       Death                                   NA
#> 4  22    0         Disease Progression                                   NA
#> 5  NA    1                        <NA> End of AE Reporting Period -2.802988
#> 6 335    0                       Death                                   NA
#> ...